Evaluation of effective factors on IL-10 signaling in B cells in patients with selective IgA deficiency
Yasser Bagheri1,2,#, Mohsen Saeidi1,2,#, Reza Yazdani3,4, Fateme Babaha3, Reza Falak5,6, Gholamreza Azizi7, Marjan Taherian5,6, Fereshteh Salami3, Yaghoob Yazdani1,2, Somayeh Sadani8, Ali Hosseini8, Morteza Motallebnezhad5,6, Hassan Abolhassani3,9, Mehdi Shekarabi5,6, Asghar Aghamohammadi3
European Cytokine Network, Vol.33, No.1, pp. 1-12, 2022, DOI:10.1684/ecn.2021.0464
Abstract Background: Selective IgA deficiency is the most prevalent form of primary immunodeficiencies. The pathogenesis of the disease is still unknown. Several studies have suggested a defect in B cell responses to IL-10; however, the main reason for this defect has not been reported. Elucidating IL-10 signaling defects and their correlation with clinical manifestations could be helpful for better understanding and treatment of the disease. Methods: In this study, 15 SIgAD patients and 15 age- and sex-matched healthy controls were included. Surface expression of transforming growth factor β receptor II (TGF-β RII), IL-10R and IgA was… More >